Nanoconstructs for theranostic application in cancer: Challenges and strategies to enhance the delivery
Open Access
- 15 March 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1101320
- https://doi.org/10.3389/fphar.2023.1101320
Abstract
Nanoconstructs are made up of nanoparticles and ligands, which can deliver the loaded cargo at the desired site of action. Various nanoparticulate platforms have been utilized for the preparation of nanoconstructs, which may serve both diagnostic as well as therapeutic purposes. Nanoconstructs are mostly used to overcome the limitations of cancer therapies, such as toxicity, nonspecific distribution of the drug, and uncontrolled release rate. The strategies employed during the design of nanoconstructs help improve the efficiency and specificity of loaded theranostic agents and make them a successful approach for cancer therapy. Nanoconstructs are designed with a sole purpose of targeting the requisite site, overcoming the barriers which hinders its right placement for desired benefit. Therefore, instead of classifying modes for delivery of nanoconstructs as actively or passively targeted systems, they are suitably classified as autonomous and nonautonomous types. At large, nanoconstructs offer numerous benefits, however they suffer from multiple challenges, too. Hence, to overcome such challenges computational modelling methods and artificial intelligence/machine learning processes are being explored. The current review provides an overview on attributes and applications offered by nanoconstructs as theranostic agent in cancer.This publication has 154 references indexed in Scilit:
- A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancerBritish Journal of Cancer, 2013
- Responsive Theranostic Systems: Integration of Diagnostic Imaging Agents and Responsive Controlled Release Drug Delivery CarriersAccounts of Chemical Research, 2011
- Multistage Nanovectors: From Concept to Novel Imaging Contrast Agents and TherapeuticsAccounts of Chemical Research, 2011
- Targeted drug delivery to tumors: Myths, reality and possibilityJournal of Controlled Release, 2011
- Frontiers in cancer nanomedicine: directing mass transport through biological barriersTrends in Biotechnology, 2010
- Nanodevices in diagnosticsWIREs Nanomedicine and Nanobiotechnology, 2010
- Drug/Dye‐Loaded, Multifunctional Iron Oxide Nanoparticles for Combined Targeted Cancer Therapy and Dual Optical/Magnetic Resonance ImagingSmall, 2009
- Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum DotsNano Letters, 2009
- Antiangiogenic Synergism of Integrin-Targeted Fumagillin Nanoparticles and Atorvastatin in AtherosclerosisJACC: Cardiovascular Imaging, 2008
- Adoptive cell transfer: a clinical path to effective cancer immunotherapyNature Reviews Cancer, 2008